A detailed history of Bellevue Group Ag transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bellevue Group Ag holds 612,691 shares of PRCT stock, worth $54.5 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
612,691
Previous 669,049 8.42%
Holding current value
$54.5 Million
Previous $40.9 Million 20.09%
% of portfolio
0.83%
Previous 0.68%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.31 - $84.99 $3.17 Million - $4.79 Million
-56,358 Reduced 8.42%
612,691 $49.1 Million
Q2 2024

Aug 14, 2024

SELL
$45.73 - $69.19 $10.1 Million - $15.3 Million
-221,065 Reduced 24.84%
669,049 $40.9 Million
Q1 2024

May 15, 2024

BUY
$40.38 - $50.75 $192,531 - $241,976
4,768 Added 0.54%
890,114 $44 Million
Q4 2023

Feb 14, 2024

SELL
$24.89 - $43.41 $73,425 - $128,059
-2,950 Reduced 0.33%
885,346 $37.1 Million
Q3 2023

Nov 14, 2023

BUY
$30.02 - $38.81 $4.41 Million - $5.7 Million
146,779 Added 19.79%
888,296 $29.1 Million
Q4 2022

Feb 14, 2023

BUY
$38.78 - $46.78 $5.9 Million - $7.12 Million
152,255 Added 25.84%
741,517 $30.8 Million
Q3 2022

Nov 14, 2022

SELL
$30.9 - $50.65 $189,046 - $309,876
-6,118 Reduced 1.03%
589,262 $24.4 Million
Q2 2022

Aug 11, 2022

BUY
$29.23 - $44.45 $9.04 Million - $13.7 Million
309,305 Added 108.12%
595,380 $19.5 Million
Q1 2022

May 13, 2022

BUY
$16.89 - $35.74 $1.9 Million - $4.02 Million
112,426 Added 64.74%
286,075 $10 Million
Q4 2021

Feb 10, 2022

BUY
$24.6 - $46.29 $581,765 - $1.09 Million
23,649 Added 15.77%
173,649 $4.34 Million
Q3 2021

Nov 12, 2021

BUY
$35.91 - $41.94 $5.39 Million - $6.29 Million
150,000 New
150,000 $5.72 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.97B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.